| scholarly article | Q13442814 |
| P50 | author | Hua Xiao | Q39637226 |
| David Wong | Q91719683 | ||
| P2093 | author name string | Lei Zhang | |
| Hui Zhou | |||
| Edward B Garon | |||
| Jay M Lee | |||
| P2860 | cites work | A small-cell lung cancer genome with complex signatures of tobacco exposure | Q24600510 |
| Somatic mutations affect key pathways in lung adenocarcinoma | Q24648102 | ||
| Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the human | Q24648354 | ||
| Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer | Q28743801 | ||
| Identification of human whole saliva protein components using proteomics. | Q30759791 | ||
| Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology | Q30980947 | ||
| Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. | Q31063929 | ||
| Role of biomarkers for early detection of lung cancer and chemoprevention | Q31095946 | ||
| Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification | Q33220914 | ||
| Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer | Q33272463 | ||
| AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma | Q33382046 | ||
| Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer | Q33466073 | ||
| Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer | Q33699291 | ||
| Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome | Q33798937 | ||
| Salivary proteomics for oral cancer biomarker discovery | Q33879157 | ||
| High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer | Q33903731 | ||
| An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer | Q33933918 | ||
| Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer | Q33983853 | ||
| Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy | Q34326254 | ||
| Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers. | Q34396094 | ||
| Using iTRAQ combined with tandem affinity purification to enhance low-abundance proteins associated with somatically mutated EGFR core complexes in lung cancer. | Q34474427 | ||
| The diagnostic applications of saliva--a review | Q34720733 | ||
| Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. | Q34766151 | ||
| Early detection of lung cancer: role of biomarkers | Q35061995 | ||
| A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers | Q36441730 | ||
| Human saliva proteome analysis and disease biomarker discovery | Q36913053 | ||
| Systematic review of baseline low-dose CT lung cancer screening. | Q36920810 | ||
| Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery | Q36997501 | ||
| Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. | Q37231517 | ||
| Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation | Q37315186 | ||
| S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis | Q37616281 | ||
| Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. | Q39801282 | ||
| Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion | Q39824178 | ||
| Proteomics and its applications for biomarker discovery in human saliva | Q41788487 | ||
| Panel of serum biomarkers for the diagnosis of lung cancer | Q46861404 | ||
| Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer | Q46964965 | ||
| Gene promoter methylation in plasma and sputum increases with lung cancer risk | Q47726867 | ||
| Management of lung nodules detected by volume CT scanning. | Q53321287 | ||
| Up-regulation of the expression of S100A8 and S100A9 in lung adenocarcinoma and its correlation with inflammation and other clinical features | Q54412494 | ||
| Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues. | Q54478920 | ||
| Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer | Q57077976 | ||
| Sputum Trace Metals Are Biomarkers of Inflammatory and Suppurative Lung Disease | Q57416181 | ||
| AZGP1 mRNA levels in normal human lung tissue correlate with lung cancer disease status | Q57763131 | ||
| Diagnosing lung cancer in exhaled breath using gold nanoparticles | Q59645539 | ||
| Predicting lung cancer by detecting aberrant promoter methylation in sputum | Q73208076 | ||
| Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study | Q79802497 | ||
| Biomarker studies abound for early detection of lung cancer | Q83130161 | ||
| P433 | issue | 2 | |
| P921 | main subject | lung cancer | Q47912 |
| saliva | Q155925 | ||
| electrophoresis | Q185098 | ||
| P304 | page(s) | M111.012112 | |
| P577 | publication date | 2011-11-17 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry | |
| P478 | volume | 11 |
| Q64235615 | A New Approach for the Diagnosis of Systemic and Oral Diseases Based on Salivary Biomolecules |
| Q51546178 | A multiple covalent crosslinked soft hydrogel for bioseparation. |
| Q35101278 | A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer. |
| Q34659915 | A review of research on salivary biomarkers for oral cancer detection |
| Q53293305 | An ionic coordination hybrid hydrogel for bioseparation. |
| Q36314392 | Application of saliva in disease diagnosis |
| Q87558547 | Avoiding acidic region streaking in two-dimensional gel electrophoresis: case study with two bacterial whole cell protein extracts |
| Q26781381 | Biomarkers for Primary Sjögren's Syndrome |
| Q28066265 | Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity |
| Q38753775 | Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives |
| Q45221297 | Continuous, quantitative monitoring of roxithromycin in human saliva by flow injection chemiluminescence analysis |
| Q34000934 | Development of transcriptomic biomarker signature in human saliva to detect lung cancer |
| Q36615746 | Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection. |
| Q57212546 | Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer |
| Q59791862 | Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers |
| Q36006446 | Extracellular RNAs: development as biomarkers of human disease |
| Q36810202 | Facile preparation of salivary extracellular vesicles for cancer proteomics. |
| Q38468546 | High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome |
| Q57205823 | Human sweat metabolomics for lung cancer screening |
| Q26798564 | Interleukin 1β-A Potential Salivary Biomarker for Cancer Progression? |
| Q45658610 | Learned and unlearned concepts in periodontal diagnostics: a 50-year perspective |
| Q35610345 | Literature-based discovery of salivary biomarkers for type 2 diabetes mellitus |
| Q41173805 | Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application |
| Q34691573 | Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine |
| Q35672964 | Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters |
| Q44201624 | More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers |
| Q51564069 | Multiplexed panel of precisely quantified salivary proteins for biomarker assessment. |
| Q35585721 | Non-coding RNAs in saliva: emerging biomarkers for molecular diagnostics |
| Q33735738 | Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer. |
| Q43463127 | Novel approaches for bioinformatic analysis of salivary RNA Sequencing data in the biomarker development process |
| Q28077072 | Oral Biofluid Biomarker Research: Current Status and Emerging Frontiers |
| Q57788655 | Potential role of nuclear magnetic resonance spectroscopy to identify salivary metabolite alterations in patients with head and neck cancer |
| Q38100750 | Proteomic biomarkers in lung cancer |
| Q26738539 | Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer |
| Q34481232 | Quantitative analysis of the intra- and inter-subject variability of the whole salivary proteome. |
| Q35226237 | RNAPro•SAL: a device for rapid and standardized collection of saliva RNA and proteins. |
| Q51106997 | Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma. |
| Q37168485 | Role of pancreatic cancer-derived exosomes in salivary biomarker development |
| Q38190061 | Saliva as a diagnostic fluid. Literature review |
| Q28069993 | Saliva in the diagnosis of diseases |
| Q35095226 | Saliva microbiota carry caries-specific functional gene signatures |
| Q45956385 | Saliva-Exosomics in Cancer: Molecular Characterization of Cancer-Derived Exosomes in Saliva. |
| Q64120390 | Salivary Exosomes as Nanocarriers for Cancer Biomarker Delivery |
| Q93080687 | Salivary Extracellular Vesicle-Associated exRNA as Cancer Biomarker |
| Q26753028 | Salivary Markers for Periodontal and General Diseases |
| Q92795186 | Salivary Microbial Dysbiosis is Associated with Systemic Inflammatory Markers and Predicted Oral Metabolites in Non-Small Cell Lung Cancer Patients |
| Q36632967 | Salivary biomarker development using genomic, proteomic and metabolomic approaches |
| Q33683154 | Salivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances |
| Q89628995 | Salivary biomarkers for diagnosis of systemic diseases and malignant tumors. A systematic review |
| Q39036176 | Salivary biomarkers in cancer detection |
| Q35394619 | Salivary extracellular noncoding RNA: emerging biomarkers for molecular diagnostics |
| Q38601695 | Salivary metabolomics in the diagnosis of oral cancer and periodontal diseases. |
| Q36104460 | Salivary peptidome profiling for diagnosis of severe early childhood caries |
| Q38667953 | The emerging landscape of salivary diagnostics. |
| Q33950002 | The human salivary proteome is radiation responsive |
| Q38191025 | Top-down analytical platforms for the characterization of the human salivary proteome |
Search more.